Galacto-oligosaccharides

Handbook of Prebiotics and Probiotics Ingredients: Health Benefits and Food Applications

Volumn , Issue , 2009, Pages 75-93

  Nauta, Arjen ^a   Bakker Zierikzee, Astrid M ^a   Schoterman, Margriet H C ^a  

^a FRIESLANDCAMPINA   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOSACCHARIDES; SACCHARIFICATION;

BENEFICIAL EFFECTS; FOOD INGREDIENTS; FRUCTO-OLIGOSACCHARIDES; GALACTO-OLIGOSACCHARIDES; HUMAN BREAST MILKS; HUMAN MILK OLIGOSACCHARIDES; MICROBIAL POPULATIONS; PREBIOTIC EFFECT;

FOOD ADDITIVES;

EID: 85057372194     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (102)

1. Gibson, G.R. and Roberfroid, M.B., Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics, J. Nutr., 125, 1401, 1995.
2. Sharon, N. and Ofek, I., Safe as mother’s milk: Carbohydrates as future anti-adhesion drugs for bacterial diseases, Glycoconj. J., 17(7-9), 659, 2000.
3. Boehm, G. and Stahl, B., Oligosaccharides, in Functional Dairy Products, Mattila, T. and Saarela, M., Eds., Woodhead Publishing, Cambridge, U.K., 2003, 203.
4. Matsumoto, K., Oligosaccharides, production, properties and applications, in Galactooligosaccharides, in Japanese Technology Reviews, Nakakuki, T., Ed, Gordon and Breach Science, Tokyo, 3(2), 90, 1993.
5. Ekhart, P.F. and Timmermans, E., Techniques for the production of transgalactosylated oligosaccharides (TOS), Bull. IDF, 313, 59, 1996.
6. Yamashita, K. and Kobata, A., Oligosaccharides of human milk, Arch. Biophys., 161, 164, 1974.
7. Boehm, G. et al., Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of fecal bifidobacteria in preterm infants, Arch. Dis. Childhood-Fetal Neonatal Ed., 86, F178, 2002.
8. Chockchaisawasdee, S. et al., Synthesis of galacto-oligosaccharide from lactose using beta-galactosidase from Kluyveromyces lactis: Studies on batch and continuous UF membrane-fitted bioreactors, Biotechnol. Bioeng., 89(4), 434, 2005.
9. Schoterman, H.C. and Timmermans, H.J.A.R., Galacto-oligosaccharides, in Prebiotics and Probiotics, LFRA Ingredients Handbook, Gibson, G.R. and Angus, F., Eds., Leatherhead Food RA Publishing, Surrey, U.K., 2000, 19.
10. Nauta, A. and Schoterman, H.C., Galacto-oligosaccharides, in Prebiotics and Probiotics, Handbook, 2nd ed., Gibson, G.R. and Angus, F., Eds., Leatherhead Food RA Publishing, Surrey, U.K., 2009, p. 31.
11. Boehm, G. et al. Prebiotic carbohydrates in human milk and formulas, Acta. Paediatr. Suppl., 94(449), 18, 2005.
12. Commission of the European Communities. Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending Directive 1999/21/EC. Off J EU, Dec. 30, 2006: L401/1-33.
13. Sako, T., Matsumoto, K., and Tanaka, R., Recent progress on research and applications of non-digestible galacto-oligosaccharides, Int. Dairy J., 9, 69, 1999.
14. Asp, N.G., Hydrolysis of galacto-oligosaccharides by human intestinal enzymes and acid, unpublished data, 1994.
15. Tanaka, R. et al., Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora, Bifidobacteria Microflora, 2, 17, 1983.
16. Boehm, G. and Stahl, B., Oligosaccharides from milk, J. Nutr., 137, 847S, 2007.
17. Editorial, Who are we? Nature, 453, 563, 2008.
18. Nicholson, J.K., Holmes, E., and Wilson, I.D., Gut microorganisms, mammalian metabolism and personalized health care, Nat. Rev. Microbiol., 3, 431, 2005.
19. Cummings, J.H., Edmond, L.M., and Magee, E.A., Dietary carbohydrates and health: Do we still need the fibre concept? Clin. Nutr. Suppl., 1, 5, 2004.
20. Dai, D. and Walker, W.A., Protective nutrients and bacterial colonization in the immature human gut, Adv. Pediatr., 46, 353, 1999.
21. Topping, D.L. and Clifton, P.M., Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides, Physiol. Rev., 81, 1031, 2001.
22. Edwards C.A. and Parrett A.M., Intestinal flora during the first months of life: New perspectives, Br. J. Nutr., 88, Suppl 1, S11, 2002.
23. Ouwehand, A.C. et al., Prebiotics and other microbial substrates for gut functionality, Curr. Opin. Biotech., 16, 212, 2005.
24. Ito, M. et al., Influence of galactooligosaccharides on the human fecal microflora, J. Nutr. Sci. Vitaminol., 39, 635, 1993.
25. Ito, M. et al., Effects of administration of galactooligosaccharides on the human faecal microflora, stool weight and abdominal sensation, Microb. Ecol. Health Dis., 3, 285, 1990.
26. Bouhnik, Y. et al., Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans, J. Nutr., 127, 444, 1997.
27. Ishikawa, F. et al., Effects of b 1-4 linked galactooligosaccharides on human faecal microflora, Bifidus Microflora, 9, 5, 1995.
28. Tamai-S., et al., Effects of galactooligosaccharides intake on human fecal flora and metabolites, J. Appl. Glycosci., 41(3), 333, 1994.
29. Chonan, O., Matsumoto, K., and Watanuki, M., Effects of galactooligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats, Biosci. Biotech. Biochem., 59(2), 236, 1995.
30. Ben, X.M. et al., Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants, Chin. Med. J., 117, 927, 2004.
31. Sawatzki, G. et al., Double-blind, randomized, multicenter trial on the effects of prebiotic galacto-oligosaccharides on the fecal flora and development of infants: First results, in The Wonders of Whey. Catch the Power, Proceedings of the 4th International Whey Conference, Chicago, 161, 2005.
32. Napoli, J.E.A.C., Brand-Miller, J.C., and Conway, P., Bifidogenic effects of feeding infant formula containing galacto-oligosaccharides in healthy formula-fed infants, Asia Pac. J. Clin. Nutr., 12, S60 [abstr. only], 2003.
33. Fanaro, S. et al., Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: Effect on intestinal flora, stool characteristics, and pH, J. Pediatr. Gastroenterol. Nutr., 41, 186, 2005.
34. Mihatsch, W.A., Hoegel, J., and Pohlandt, F., Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants, Acta Pediatr., 95, 843, 2006.
35. Moro, G. et al., Dosage related bifidogenic effects of galacto and fructo-oligosaccharides in formula-fed term infants, J. Paediatr. Gastroenterol. Nutr., 34, 291, 2002.
36. Bakker-Zierikzee, A.M. et al., Effects of infant formula containing a mixture of galactoand fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first four months of life, Br. J. Nutr., 94, 783, 2005.
37. Haarman, M. and Knol, J., Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula, Appl. Environ. Microbiol., 71, 2318, 2005.
38. Haarman, M. and Knol, J., Quantitative real-time PCR analysis of fecal lactobacillus species in infants receiving a prebiotic infant formula, Appl. Environ. Microbiol., 72, 2359, 2006.
39. Knol, J. et al., Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: More like breast-fed infants, J. Pediatr. Gastroenterol. Nutr., 40, 36, 2005a.
40. Knol, J. et al., Increase of fecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants, Acta Paediatr., 94, 31, 2005b.
41. Scholtens, P.A. et al., Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: A randomised controlled clinical trial, J. Pediatr. Gastroenterol. Nutr., 42(5), 553, 2006.
42. Shadid R. et al., Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity-A randomized, double-blind, placebo-controlled study, Am. J. Clin. Nutr., 86, 1426, 2007.
43. Rousseau, V. et al., Prebiotic effects of oligosaccharides on selected vaginal lactobacilli and pathogenic microorganisms, Anaerobe, 11, 145, 2005.
44. Brunser, O. et al., Effect of an infant formula with prebiotics on the intestinal microbiota after antibiotic treatment, J. Pediatr. Gastroenterol. Nutr., 40, 691, 2005.
45. Piirainen, L. et al., In school-aged children a combination of galacto-oligosaccharides and Lactobacillus GG increases bifidobacteria more than Lactobacillus GG on its own, Ann. Nutr. Metab., 52, 204, 2008.
46. Fooks, L.J., and Gibson, G.R., Probiotics as modulators of the gut flora, Br. J. Nutr., 88 Suppl. 1, S39, 2002.
47. Gibson, G.R., McCartney, A.L., and Rastall, R.A., Prebiotics and resistance to gastrointestinal infections, Br. J. Nutr., 93 (Suppl. 1), S31, 2005.
48. Gibson, G.R. and Wang, X., Regulatory effects of bifidobacteria on the growth of other colonic bacteria, J. Appl. Bacteriol., 77, 412, 1994.
49. Anand, S.K., Srinivasan, R.A. and Rao, L.K., Antibacterial activity associated with Bifidobacterium bifidum, II, Cult. Dairy Prod. J., Feb., 21, 1985.
50. Kunz, C. et al. Oligosaccharides in human milk: Structural, functional, and metabolic aspects, Ann. Rev. Nutr., 20, 699, 2000.
51. Tzortis, G. et al., A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo, J. Nutr., 135, 1726, 2005.
52. Shoaf, K. et al., Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells, Infect. Immun., 74, 6920, 2006.
53. Macfarlane, G.T., Steed, H., and Macfarlane, S., Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics, J. Appl. Microbiol., 104, 305, 2008.
54. Lindsay, J.O. et al., Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease, Gut, 55, 348, 2006.
55. Malinen, E. et al., Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR, Am. J. Gastroenterol., 100(2), 373, 2005.
56. Rowland, I.R. and Tanaka, R., The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human fecal microflora, J. Appl. Bacteriol., 74, 667, 1993.
57. Ito, M. et al., Effects of transgalactosylated disaccharides on the human intestinal microflora and their metabolism, J. Nutr. Sci. Vitaminol., 39, 279, 1993.
58. Kawakami, K. et al., Dietary galacto-oligosaccharides mixture can suppress serum phenol and p-cresol levels in rats fed tyrosine diet, J. Nutr. Sci Vitaminol., 51(3), 182, 2005.
59. Wijnands, M.V.W. et al., A comparison of the effects of dietary cellulose and fermentable galacto-oligosaccharide, in a rat model of colorectal carcinogenesis: Fermentable fibre confers greater protection than non-fermentable fibre in both high and low fat backgrounds, Carcinogenesis, 20(4), 651, 1999.
60. Chonan, O. and Watanuki, M., Effect of galactooligosaccharides on calcium absorption in rats, J. Nutr. Sci. Vitaminol., 41, 95, 1995.
61. Chonan, O. and Watanuki, M., The effect of 6′-galactooligosaccharides on bone mineralization of rats adapted to different levels of dietary calcium, Int. J. Vit. Nutr. Res., 66, 244, 1996.
62. Yanahira, S. et al., Effects of lactitol-oligosaccharides on calcium and magnesium absorption in rats, J. Nutr. Sci. Vitaminol., 43, 123, 1997.
63. van den Heuvel, E.G.H.M., Schoterman, M.H.C., and Muijs, T., Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women, J. Nutr., 130, 2938, 2000.
64. Pérez-Conesa, D. et al., Bioavailability of calcium, magnesium and phosphorus in rats fed probiotic, prebiotic and symbiotic powder follow-up infant formulas and their effect on physiological and nutritional parameters, J. Sci. Food Agric., 86(14), 2327, 2006.
65. Scholz-Ahrens, K.E. et al., Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure, J. Nutr., 137(3 Suppl. 2), 838S, 2007.
66. Deguchi, Y. et al. Effects of beta 1-4 galactooligosaccharides administration on defaecation of healthy volunteers with a tendency to constipation, Jap. J. Nutr., 55(1), 13, 1997.
67. Teuri, U. and Korpela, R., Galacto-oligosaccharides relieve constipation in elderly people, Ann. Nutr. Metab., 42, 319, 1998.
68. Shitara, A., Effect of 4′-galactosyl-lactose on constipated old patients and intestinal bacteria, Med. Biol., 117, 371, 1988.
69. Puccio, G. et al., Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics, Nutrition, 23(1), 1, 2007.
70. Salminen, S. et al. Functional food science and gastrointestinal physiology and function, Br. J. Nutr., 80 (Suppl. 1), S147, 1998.
71. Tomomatsu, H., Health effects of oligosaccharides. Ingestion of oligosaccharides increases the bifidobacteria population in the colon, which in turn contributes to human health in many ways, Food Technol., 61, 1994.
72. Smith, D.W. and Nagler-Anderson, C., Preventing intolerance: The induction of nonresponsiveness to dietary and microbial antigens in the intestinal mucosa, J. Immunol., 3851, 2005.
73. Schley, P.D. and Field, C.J., The immune-enhancing effects of dietary fibers and prebiotics, Br. J. Nutr., 87, S221, 2002.
74. Norin, E. and Midtvedt, T., Interactions of microflora associated characteristics of the host; non-immune function, Micr. Ecol. Health Dis., 11, 186, 2000.
75. Isolauri, E., Probiotics in human disease, Am. J. Clin. Nutr., 73(6), 1142S, 2001.
76. Eiwegger, T. et al., Human milk-derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro, Pediatr. Res., 56(4), 620, 2004.
77. Vos, A. et al., Immune-modulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates, Crit. Rev. Immunol., 27, 97, 2007.
78. Inan M.S. et al., The luminal short-chain fatty acid butyrate modulates NF-κβ activity in a human colonic epithelial cell line, Gastroenterology, 118, 724, 2000.
79. Yin, L., Laevsky, G., and Giardina, C., Butyrate suppression of colonocyte NF-κβ activation and cellular proteasome activity, J. Biol. Chem., 276, 44641, 2001.
80. Cavaglieri, C.R. et al., Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes, Life Sci., 73, 1683, 2003.
81. Tedelind, S. et al., Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease, World J. Gastroenterol., 13, 2826, 2007.
82. Vos, A.P. et al., A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model, Int. Immunopharmacol., 6, 1277, 2006.
83. Van der Waaij, L.A., Limburg, P.C., Mesander, G., Van der Waaij, D., In vivo IgA coating of anaerobic bacteria in human faeces, Gut, 38, 348, 1996.
84. Hanson, L.Å. and Korotkova, M., The role of breastfeeding in prevention of neonatal infection, Semin. Neonatol., 7, 275, 2002.
85. Bakker-Zierikzee, A.M. et al., fecal sIgA secretion in infants fed on pre- or probiotic infant formula, Pediatr. Allergy Immunol., 17, 134, 2006.
86. Scholtens, P.A. et al., Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructooligosaccharides, J. Nutr., 138(6), 1141, 2008.
87. Majamaa, H. and Isolauri, E., Probiotics: A novel approach in the management of food allergy, J. Allergy Clin. Immunol., 99, 179, 1997.
88. Strobel, S., Mechanisms in adverse reactions to food. Mechanisms of tolerance and sensitization in the intestine and other organs of the body, Allergy, 50(20 Suppl.), 18, 1995.
89. Viljanen, M. et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: A double-blind placebo-controlled trial, Allergy, 60, 494, 2005.
90. Rosenfeldt, V. et al., Effect of probiotic Lactobacillus strains in children with atopic dermatitis, J. Allergy Clin. Immunol., 111, 389, 2003.
91. Weston, S. et al., Effects of probiotics on atopic dermatitis: A randomized controlled trial, Arch. Dis. Child., 90, 892, 2005.
92. Gdalevich, M. et al., Breast-feeding and the onset of atopic dermatitis in childhood: A systematic review and meta-analysis of prospective studies, J. Am. Acad. Dermatol., 45(4), 520, 2001.
93. Gdalevich, M., Mimouni, D., and Mimouni, M., Breast-feeding and the risk of bronchial asthma in childhood: A systematic review with meta-analysis of prospective studies, J. Pediatr., 139(2), 261, 2001.
94. van Odijk, J. et al. Breastfeeding and allergic disease: A multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations, Allergy, 58(9), 833, 2003.
95. Moro, G. et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age, Arch. Dis. Child., 91, 814, 2006.
96. Garssen, J., Vos, P., M’Rabet, L., et al., Oral exposure to a mixture of galacto-oligosacharides and long chain fructo-oligosaccharides as a new concept for allergy prevention, Allergy Clin. Immunol. Int. (Suppl. 1), 572, 2005.
97. Garssen, J., Moro, G., et al., A mixture of short chain galacto-oligosaccharides and long chain fructo-oligosaccharides induces an anti-allergic immunoglobulin profile in infants at risk, Poster PG4-15. Presented at ESPGHAN 2007, Barcelona, Spain, 9-12 May 2007.
98. van Hoffen, E. et al., A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy, Allergy, DOI: 10.1111/j.1398-9995.2008.01765.x, 2008.
99. Nauta, A.J. et al., A specific mixture of short-chain galacto-oligosaccharides and longchain fructo-oligosaccharides induced an anti-allergic Ig profile in infants at risk for allergy, Proc. Nutr. Soc., 2008.
100. Kukkonen, K., Savilahti, A., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T., and Kuitunen, M., Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial., J. Allergy Clin. Immunol., 119(1), 192, 2007.
101. Vos, A.P. et al., Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice, Int. Immunopharmacol., 7(12), 1582, 2007.
102. Arslanoglu, S., Moro, G.E., Schmitt, J., Tandoi, L., Rizzardi, S., and Boehm, G., Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life, J. Nutr., 138(6), 1091, 2008.